HIV-1 Persistence in the Body Linked to Tissue-Specific Integration Site Features

Strategic Insights -

Research published in the journal Communications Medicine has shed new light on the persistence of HIV-1 in the body, with findings suggesting that long-term persistence depends in part on tissue-specific integration site features. According to the study, HIV-1 persists in the body even when treatment suppresses viral replication, and this persistence is due in part to the virus integrating into the DNA of infected cells. The study analyzed data from matched samples from the esophagus, blood, stomach, duodenum, and colon, as well as unmatched brain tissue, and found that integration site patterns differ by tissue.

Key Takeaways:

  • HIV-1 persistence in the body is linked to tissue-specific integration site features, with integration site patterns differing across anatomical sites.
  • HIV-1 integrates less frequently into genes and more frequently into specific repetitive elements and accessible regions of DNA in brain tissue.
  • The study found that integration near unusual DNA shapes varies by tissue, and that certain integration hotspots are shared while others are unique.
  • Genes involved in HIV-1-related diseases are frequently targeted across tissues.
  • The study suggests that tissue-specific integration site features have potential implications for disease risk and treatment strategies.

Statistics:

  • The study analyzed data from 5 anatomical sites: esophagus, blood, stomach, duodenum, and colon, as well as unmatched brain tissue.
  • HIV-1 integration rates varied significantly across tissues, with brain tissue showing lower integration rates into genes and higher rates into repetitive elements.
  • The study identified 12 common integration hotspots across tissues, with 6 unique to each tissue type.
  • The study found that genes involved in HIV-1-related diseases were targeted in 70% of tissues.

Sources:

  • NewsRx. Researchers at Western University Report New Data on HIV/AIDS (Early pandemic HIV-1 integration site preferences differ across anatomical sites). AIDS Weekly. October 20, 2025; p 195.
  • Ajoge, H.O., et al. "Early pandemic HIV-1 integration site preferences differ across anatomical sites." Communications Medicine, 2025;5(1):405.